{
    "root": "e29d6ea1-1374-4572-ad7e-b0c2ea48ca04",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "metoprolol succinate",
    "value": "20250201",
    "ingredients": [
        {
            "name": "METOPROLOL SUCCINATE",
            "code": "TH25PD4CCB"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "ETHYLCELLULOSE (10 MPA.S)",
            "code": "3DYK7UYZ62"
        },
        {
            "name": "GLYCERIN",
            "code": "PDC6A3C0OX"
        },
        {
            "name": "HYPROMELLOSE, UNSPECIFIED",
            "code": "3NXW29V3WO"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "METHYLCELLULOSE (15 MPA.S)",
            "code": "NPU9M2E6L8"
        },
        {
            "name": "POLYETHYLENE GLYCOL, UNSPECIFIED",
            "code": "3WJQ0SDW1A"
        },
        {
            "name": "POVIDONE K30",
            "code": "U725QWY32X"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        }
    ],
    "indications": "metoprolol succinate extended-release tablets , beta-adrenergic blocker indicated treatment : • hypertension , lower blood pressure . lowering blood pressure reduces risk fatal non-fatal cardiovascular events , primarily strokes myocardial infarctions . ( 1.1 ) • angina pectoris . ( 1.2 ) • heart failure , reduce risk cardiovascular mortality heart failure hospitalizations patients heart failure ( 1.3 )",
    "contraindications": "• administer daily . titrate weekly longer intervals needed tolerated . ( 2 ) • hypertension : starting dose 25 100 mg. ( 2.1 ) • angina pectoris : starting dose 100 mg. ( 2.2 ) • heart failure : starting dose 12.5 25 mg. ( 2.3 ) • switching immediate-release metoprolol metoprolol succinate extended-release tablets : total daily dose metoprolol succinate extended-release tablets . ( 2 )",
    "warningsAndPrecautions": "metoprolol succinate extended-release tablets usp , 50 mg white off-white color , round shaped , biconvex coated tablets , debossed `` 565 `` one side break line side supplied follows : ndc 82804-198-90 bottles 90 tablets storage store 20° 25°c ( 68° 77°f ) [ usp controlled room temperature ] . dispense tight container ( usp ) .",
    "adverseReactions": "• known hypersensitivity product components . ( 4 ) • severe bradycardia : greater first degree heart block , sick sinus syndrome without pacemaker . ( 4 ) • cardiogenic shock decompensated heart failure . ( 4 )",
    "indications_original": "Metoprolol succinate extended-release tablets, are a beta-adrenergic blocker indicated for the treatment of: • Hypertension, to lower blood pressure. Lowering blood      pressure reduces the risk of fatal and non-fatal cardiovascular events,      primarily strokes and myocardial infarctions. (1.1) • Angina Pectoris. (1.2) • Heart Failure, to reduce the risk of      cardiovascular mortality and heart failure hospitalizations in patients with heart      failure (1.3)",
    "contraindications_original": "• Administer once daily. Titrate at weekly or longer      intervals as needed and tolerated. (2) • Hypertension: Starting dose is 25 to 100 mg. (2.1) • Angina Pectoris: Starting dose is 100 mg. (2.2) • Heart Failure: Starting dose is 12.5 or 25 mg. (2.3) • Switching from immediate-release metoprolol to      metoprolol succinate extended-release tablets: use the same total daily      dose of metoprolol succinate extended-release tablets. (2)",
    "warningsAndPrecautions_original": "Metoprolol Succinate Extended-release Tablets USP, 50 mg are white to off-white color, round shaped, biconvex coated tablets, debossed with \"565\" on one side and break line on the other side and are supplied as follows:\n                  NDC 82804-198-90 in bottles of 90 tablets\n                  \n                     Storage\n                  \n                  Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. \n                  Dispense in a tight container (USP).",
    "adverseReactions_original": "• Known hypersensitivity to product components. (4) • Severe bradycardia: Greater than first degree heart block, or sick sinus syndrome without a pacemaker. (4) • Cardiogenic shock or decompensated heart failure. (4)"
}